Biomedical subjects
Publications and source records attributed to C M Duran.
A series of 122 consecutive patients with left atrial thrombosis is reviewed. Positive diagnosis was achieved in only 40 cases (36%) based on the angiographic findings and the presence of coronary fistula. The main cause of mortality and morbidity was cerebrovascular embolism. A change in our surgical technique, including the occlusion of the mitral orifice, has so far eliminated this problem.
In an attempt to clarify the indications for tricuspid valve operations, we studied 150 patients who had preoperative and postoperative full catheterization including biventriculography. Seventy-eight patients had organic and 72 had functional tricuspid insufficiency (TI). One hundred nineteen underwent tricuspid repair (46 commissurotomies and 115 annulopasties), and in 31 the tricuspid disease was surgically ignored. Ninety seven percent of all patients with hemodynamically correct left-side repair were in Class I or II, regardless of the state of the tricuspid valve. Repair of lesions on the left side determined the postoperative cardiac index. In the "repaired group," 38% had residual gradients and 30% residual TI. Eighty percent of patients with low postoperative pulmonary resistance had no TI, compared with 53% with high pulmonary resistance. In the "ignored group," all 14 patients with organic disease had residual TI, as did nine of 17 with functional disease but with elevated pulmonary resistance. The right ventricular end-diastolic volume (RVEDV) decreased 37% in the "repaired" (p < 0.001) and 36% in the "ignored" group (p < 0.01) if tricuspid competence was achieved, but remained high if TI persisted. Because of these data, which emphasize the need for an early and correct repair of the left-side lesions, we believe that (1) functional TI can be ignored only in patients with predictable and significant reduction in pulmonary resistance and (2) organic disease must be repaired.
Explore the source record for details and available documents.
Patches of glutaraldehyde-preserved porcine pericardium were transplanted orthotopically into 20 dogs to see if they might make a satisfactory pericardial substitute. Two dogs had mediastinal infections and were excluded from this study. All animals were reoperated on at regular intervals between 15 and 300 days. In 15 dogs there were no adhesions between the porcine pericardium and the host's epicardium. Histological study showed healing between both pericardiums and no degenerative changes in transplanted pericardium. Glutaraldehyde porcine pericardium has been utilized in 8 patients to close the pericardial cavity. There have been no problems related to the pericardial grafts after a maximum follow-up of 9 months.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVES: Transmyocardial laser revascularization (TMLR) of the ischemic myocardium has been recognized as a potentially useful adjunct in the treatment of coronary arterial heart disease. Although there are methods to visualize the induced channels, they have been complex or concerned with long-term patency. The present work was designed as a feasibility study to determine whether contrast echocardiography could provide a simple and rapid method to assist the surgeon in determining the extent of the TMLR-treated area. METHODS: Transmyocardial channels were created in five Targhee adult sheep myocardium using a Holmium-YAG laser over the area supplied by the second diagonal branch. A commercially developed echocontrast agent (Optison) was injected into the left atrium. RESULTS: Passage of the dye through the myocardium was observed by epicardial echocardiography in all the animals. CONCLUSION: The current study shows that contrast echocardiography using a newer generation contrast agent capable of enhanced and persistent opacification of left ventricular cavity may serve as an effective tool in delineating intraoperatively the area of myocardium treated with TMLR.
Myxomatous disease is the leading cause of mitral valve regurgitation in the developed world. Although posterior mitral leaflet (PML) prolapse is the most common cause of regurgitation and of repair, lesions of the anterior mitral leaflet (AML) are often considered beyond the possibilities of repair. The surgical anatomy and pathology of the AML and a precise terminology for the location of the lesions are described. The surgical maneuvers for commissural prolapse, chordal shortening, chordal replacement, leaflet resection, and annuloplasty are also described. The advantages and limitations of each maneuver are discussed. It is concluded that a flexible approach to the repair of the AML is necessary to adapt the best technique for each type of lesion. No particular technique can be applied systematically to all lesions. It is the author's contention that the majority of AML lesions can be repaired safely.
The management of young patients with valvular heart disease is a difficult problem in developing countries. At our Institution, 765 valves were operated upon in 523 patients over a period of two years. Rheumatic etiology was seen in 70% of the valves and 60% of all the valves were repaired. The hospital mortality and morbidity in the form of thromboembolic episodes were less in the repair group; 35 valves in 26 patients had to be reoperated upon for instability of the primary repair. Despite this high and early reoperation rate in the repair group and considering the higher mortality plus the problems of anticoagulation and limited durability of bioprostheses in the replacement group, conservation of the patient's own valve remains a better alternative in the long-term.
From August 1977 to August 1982, aortic valve replacement (AVR) with the Ionescu-Shiley pericardial valve was carried out on 172 patients. Hospital mortality was 4.3% for solitary AVR and 15% for patients with additional surgery. The expected 5 year survival rate was 96.7% for patients with isolated AVR and 81.8% for associated AVR. Cumulative duration of follow-up was 3,892 patient-months (mean 26.8 months per patient). The actuarial projection of freedom from thromboembolic episodes was 98.6% for isolated AVR and 91.6% for associated AVR. Seven patients underwent reoperation: 4 for infective endocarditis, 1 for massive perivalvular leak, 2 for primary tissue failure. Although the actuarial rate of freedom from valve failure for isolated AVR with Ionescu-Shiley valve was 93.7% at 5 years after surgery, the next few years of follow-up will be critical in determining the superiority of this valve over the porcine bioprostheses.